1. Home
  2. CD vs LAB Comparison

CD vs LAB Comparison

Compare CD & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chaince Digital Holdings Inc. Ordinary Shares

CD

Chaince Digital Holdings Inc. Ordinary Shares

HOLD

Current Price

$2.67

Market Cap

382.5M

Sector

Technology

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.81

Market Cap

326.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CD
LAB
Founded
2011
1999
Country
United States
United States
Employees
13
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
382.5M
326.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
CD
LAB
Price
$2.67
$0.81
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
140.0K
2.0M
Earning Date
08-31-2023
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.54
EPS
N/A
0.26
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.63
P/E Ratio
N/A
$2.99
Revenue Growth
N/A
N/A
52 Week Low
$2.73
$0.70
52 Week High
$14.10
$1.72

Technical Indicators

Market Signals
Indicator
CD
LAB
Relative Strength Index (RSI) 38.24 42.12
Support Level $2.96 $0.75
Resistance Level $3.22 $0.94
Average True Range (ATR) 0.23 0.07
MACD 0.11 -0.00
Stochastic Oscillator 56.52 8.43

Price Performance

Historical Comparison
CD
LAB

About CD Chaince Digital Holdings Inc. Ordinary Shares

Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: